Novo Nordisk Canada Inc.

What they're asking for

In the registry's own words. Descriptions are only filed for meetings since mid-2024.

1. Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes.

   June 2, 2026 · Tom Kmiec · Conservative · Health; International Trade

2. Advocating in support of Bill S-201, An Act respecting a national framework on sickle cell disease.

   March 24, 2026 · Michael Coteau · Liberal · Health

3. Advocate for the implementation of a federal diabetes and obesity strategy.

   March 17, 2026 · Jacques Ramsay · Liberal · Health; International Trade

4. Communication around existing drug shortages and shared solutions to mitigate the impact on Canadians.

   February 23, 2026 · Karim Bardeesy · Liberal · Health; International Trade

5. Advocate for the establishment of public-private partnerships to support chronic disease prevention.

   February 10, 2026 · Helena Jaczek · Liberal · Health; Research and Development

6. Bill C-64, the Pharmacare Act, with respect to definitional questions related to terms contained in Section 6.1, and concerns regarding the increased risk of drug shortages.

   October 7, 2025 · Sonia Sidhu · Liberal · Health; International Trade

Full meeting log

34 MP-directed communications since January 2024, from the Registry of Lobbyists.